Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51532 (
transcriptional activator
)
6,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have identified two novel human SCAN domain genes ZNF396 and
ZNF397
, which are clustered within the region of chromosome 18q12. Three isoforms of ZNF396 transcript, 1.5, 2.5 and 3.9-kb, are expressed highly in liver. Four isoforms of
ZNF397
transcript, 1.7, 2.5, 7.0 and 9.0-kb, are expressed in a variety of tissues, with varying levels. The SCAN-(C(2)H(2))(X) genes encode two distinct proteins due to a unique alternative splicing mechanism. Both ZNF396-fu (full zinc fingers) and
ZNF397
-fu consist of a SCAN domain in the N-terminal region and many consecutive C(2)H(2) zinc finger repeats in the C-terminal region. ZNF396-nf (no zinc fingers) and
ZNF397
-nf encode 210 and 198 amino acids, respectively, containing the SCAN domain only. ZNF396-fu, ZNF396-nf,
ZNF397
-fu or
ZNF397
-nf can homo-associate, while ZNF396-fu hetero-associates with ZNF396-nf, and
ZNF397
-fu hetero-associates with
ZNF397
-nf. ZNF396-nf and
ZNF397
-nf polypeptides are expressed diffusely in the cells, while ZNF396-fu and
ZNF397
-fu polypeptides target specifically to the nuclei. ZNF396-fu, ZNF396-nf and
ZNF397
-nf can repress reporter gene transcription, with
ZNF397
-nf having the strongest repression activity. Deletion analysis revealed that
ZNF397
-fu is a
transcriptional activator
without its nine zinc finger repeats.
...
PMID:Identification and characterization of two novel human SCAN domain-containing zinc finger genes ZNF396 and ZNF397. 1280 47